Insiders · Profile

Townsend Richard Nolan

Chief Executive Officer at Lexeo Therapeutics. Filing since 13 May 2024. CIK 0001995218

Company
Date
Role
Action
Shares
Amount
Of holding
18 Aug 2026
Chief Executive Officer
Sold at will
3,345
$16.56K
0.9%
1 Jul 2026
Chief Executive Officer
Sold at will
25,947
$116.24K
6.4%
18 May 2026
Chief Executive Officer
Sold at will
3,342
$16.93K
1.0%
6 Apr 2026
Chief Executive Officer
Sold on a plan
55,000
$313.14K
13.9%
18 Feb 2026
Chief Executive Officer
Sold at will
10,173
$64.92K
2.5%
18 Nov 2025
Chief Executive Officer
Sold at will
1,127
$10.45K
0.5%
17 Oct 2025
Chief Executive Officer
Sold at will
13,133
$117.44K
5.1%
18 Aug 2025
Chief Executive Officer
Sold at will
2,735
$12.77K
1.2%
16 May 2025
Chief Executive Officer
Sold at will
1,074
$2.98K
0.5%
19 Feb 2025
Chief Executive Officer
Sold at will
4,326
$19.09K
1.9%
10 Dec 2024
Chief Executive Officer
Sold on a plan
2,500
$20.49K
2.0%
11 Nov 2024
Chief Executive Officer
Sold on a plan
2,500
$19.56K
2.0%
10 Oct 2024
Chief Executive Officer
Sold on a plan
5,000
$40.50K
4.0%
10 Sep 2024
Chief Executive Officer
Sold on a plan
5,000
$53.27K
4.0%
12 Aug 2024
Chief Executive Officer
Sold on a plan
5,000
$57.63K
4.0%
11 Jul 2024
Chief Executive Officer
Sold on a plan
28,031
$478.41K
18.8%
10 Jul 2024
Chief Executive Officer
Sold on a plan
26,969
$444.98K
15.3%
10 Jun 2024
Chief Executive Officer
Sold on a plan
5,000
$88.26K
2.8%
13 May 2024
Chief Executive Officer
Sold on a plan
5,000
$66.09K
2.8%
19 decisions on file.